Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Renaissance Capital Greenwich Fund (NY: IPOS)
21.64 USD  +0.01 (+0.04%)
Official Closing Price  /  Updated: 7:59 PM EDT, Sep 19, 2019  /  Add to My Watchlist      
View: Quote News
Fund Overview
Renaissance Capital Greenwich Fund
Sector
Exchange Traded NY
Net Assets 2.16M
Inception Date
Related Funds
Quote
Price 21.64
Volume 100
Last Trade Sep 19, 7:59pm
Change (%)
+0.01 (0.04%)
Prev. Close 21.64
YTD %
+15.56%
Dividend Yield 0.97%
Performance
YTD
+2.91 (15.56%)
1 Month
+0.83 (4.00%)
3 Month
-0.02 (-0.09%)
6 Month
+0.56 (2.65%)
1 Year
-0.54 (-2.41%)
Chart
Charting
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Exagen Opens Above IPO Price
Exagen (NASDAQ: XGN) made its public debut Thursday morning, opening at $16.80after being priced at $14 per share. The company ... Read More
from Benzinga
Datadog Opens Above IPO Price
Datadog, Inc. (NASDAQ: DDOG) made its public debut on Thursday morning, opening at $40.35per share after being priced at ... Read More
from Benzinga
Top News
More News
Ping Identity Holding Opens Above IPO Price
Ping Identity Holding Corp (NASDAQ: PING) made its public debut on Thursday morning, opening at $18.75 after being priced at $15 per ... Read More
from Benzinga
The Daily Biotech Pulse: China Biologics Receives Buyout Offer, Provention Bio Offering, Exagen IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... Read More
from Benzinga
Ping Identity Holding IPO: What You Need To Know
An identity management software provider is part of the IPO slate for the week. Can the company create an identity for itself among ... Read More
from Benzinga
WeWork's Adam Neumann wants to live forever, be king of the world and the first trillionaire, says report
According to a report in the Wall Street Journal, WeWork co-founder Adam Neumann has floated the idea of becoming Israel's prime minister or leader of the world. Read More
from CNBC.com News
Datadog IPO: What You Need To Know
A cloud-monitoring services company that boasts of strong revenue growth and an enviable market potential is testing the IPO waters this ... Read More
from Benzinga
IGM Biosciences Opens Above IPO Price
IGM Biosciences (NASDAQ: IGMS) made its public debut Wednesday morning, opening at $18.31 after being priced at $16 per share. The ... Read More
from Benzinga
Envista Holdings Opens Above IPO Price
Envista Holdings (NYSE: NVST) made its public debut Wednesday morning, opening at $25.65 after being priced at $22 per share. The ... Read More
from Benzinga
This year's IPO class is the least profitable of any year since the tech bubble
This year's initial public offerings are performing like it's 1999 — and not in a good way. Read More
from CNBC.com News
IGM Biosciences IPO: What You Need To Know
A pre-phase 1 biotech working on antibodies targeting blood cancer is seeking a public listing this week, with a recent amendment to the ... Read More
from Benzinga
Envista Holdings IPO: What You Need To Know
Envista Holdings Corporation, a dental products company that's a spinoff of Danaher Corporation (NYSE: DHR), is expected to go ... Read More
from Benzinga
WeWork still plans to go public this year after delaying IPO to sharpen the story for investors
WeWork hopes to sharpen its story for investors as it works to get its on-again, off-again IPO back on track. Read More
from CNBC.com News
Why A Foreign Company Would Want To Cross-Trade In The US
This article is from Benzinga’s Partner Content team For many foreign companies that are publicly traded (or one day would like ... Read More
from Benzinga
WeWork Delays IPO Plans For Now
Jim Cramer is sort of getting what he wished for: WeWork has made the decision to hold off on its highly publicized initial public ... Read More
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.